|
Pharmaceutical corporations are the primary purchasers of the data, utilizing the details to far better target their marketing to individual physicians, and also to direct safety messages to doctors, to track disease progression, to aid law enforcement, to implement risk-mitigation programs and to do post-marketing surveillance needed by the FDA, according to the appeals court decision.
|
